Drug Patents owned by Noden Pharma
1. List of Tekturna drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8617595 | NODEN PHARMA | Galenic formulations of organic compounds |
Feb, 2026
(3 years from now) | |
|
US8617595
(Pediatric) | NODEN PHARMA | Galenic formulations of organic compounds |
Aug, 2026
(3 years from now) | |
Drugs and Companies using ALISKIREN HEMIFUMARATE ingredient
Market Authorisation Date: 05 March, 2007
Treatment: NA
Dosage: TABLET;ORAL
How can I launch a generic of TEKTURNA before it's patent expiration?
More Information on Dosage
2. List of Tekturna Hct drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9023893 | NODEN PHARMA | Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
Mar, 2022
(11 months ago) | |
| US8618172 | NODEN PHARMA | Galenical formulations of organic compounds |
Jul, 2028
(5 years from now) | |
Drugs and Companies using ALISKIREN HEMIFUMARATE; HYDROCHLOROTHIAZIDE ingredient
Market Authorisation Date: 18 January, 2008
Treatment: NA
Dosage: TABLET;ORAL
How can I launch a generic of TEKTURNA HCT before it's patent expiration?
More Information on Dosage
availability in other generic markets.
Click on the highlighted region to filter.
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic